No products in the cart.
Royal Philips NV received a letter from the US Food and Drug Administration warning that three manufacturing sites don’t meet standards, a blow to efforts to draw a line under high-profile issues with some of its products.
Royal Philips NV received a letter from the US Food and Drug Administration warning that three manufacturing sites don’t meet standards, a blow to efforts to draw a line under high-profile issues with some of its products.